| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/19/1995 | EP0663445A1 Process for producing 7beta-(4-carboxybutanamido)-cephalosporanic acid acylase ("GA) enzyme |
| 07/19/1995 | EP0663444A1 Cell lines, maturation factors and use of said cell lines and factors |
| 07/19/1995 | EP0663443A1 Dextranase enzyme, method for its production and DNA encoding the enzyme |
| 07/19/1995 | EP0663404A1 Antibodies for the detection of Salmonella |
| 07/19/1995 | EP0663403A1 Vector vaccines of bovine herpesvirus I |
| 07/19/1995 | EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 07/19/1995 | EP0663013A1 Method for delivering nucleic acids into cells |
| 07/19/1995 | EP0663012A1 CYANOBACTERIAL AND PLANT ACETYL-CoA CARBOXYLASE |
| 07/19/1995 | EP0663011A1 Synthesis of quinic acid from glucose |
| 07/19/1995 | EP0663010A1 Methods for increasing secretion of overexpressed proteins |
| 07/19/1995 | EP0663009A1 High molecular weight desulphatohirudin |
| 07/19/1995 | EP0663008A1 Improvements in or relating to immune response modification |
| 07/19/1995 | EP0663007A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 07/19/1995 | EP0663006A1 Human calcitonin receptor |
| 07/19/1995 | EP0663004A1 Methods for stonewashing fabrics using endoglucanases |
| 07/19/1995 | EP0662976A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | EP0662782A1 Pp14-based therapy |
| 07/19/1995 | EP0646129A4 Receptor-type tyrosine kinase-like molecules. |
| 07/19/1995 | EP0638168A4 Capillary electrophoresis molecular weight separation of biomolecules using a polymer-containing solution. |
| 07/19/1995 | EP0620861A4 Restriction amplification assay. |
| 07/19/1995 | EP0546049B1 A method for rapid selection of efficient secretion vectors |
| 07/19/1995 | EP0527760B1 Methods and compositions for vaccination against hiv |
| 07/19/1995 | EP0513227B1 Monoclonal antibodies which differentiate between native and modified sequence proteins |
| 07/19/1995 | EP0497798B1 Process for conducting site-directed mutagenesis |
| 07/19/1995 | EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
| 07/19/1995 | EP0386240B1 Novel polypeptide compounds |
| 07/19/1995 | EP0358739B1 Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use thereof |
| 07/19/1995 | EP0332677B1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 07/19/1995 | EP0198015B2 Production of streptavidin-like polypeptides |
| 07/18/1995 | US5434340 Transgenic mice depleted in mature T-cells and methods for making transgenic mice |
| 07/18/1995 | US5434283 Edible endogenous vegetable oil extracted from rapeseeds of reduced stearic and palmitic saturated fatty acid content |
| 07/18/1995 | US5434257 Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
| 07/18/1995 | US5434245 Osteocalcin |
| 07/18/1995 | US5434135 Growth factor compositions, preparation and use |
| 07/18/1995 | US5434133 CNP analog peptides and their use |
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | US5434086 Method of testing potential cystic fibrosis treating compounds using cells in culture |
| 07/18/1995 | US5434078 Fermentation broth comprising xanthan gum from dairy permeates and other filtered dairy products |
| 07/18/1995 | US5434077 Borrelia burgdorferi strain 257 |
| 07/18/1995 | US5434074 Cytomegalovirus proteinase |
| 07/18/1995 | US5434073 Fibrinolytic and anti-thrombotic cleavable dimers |
| 07/18/1995 | US5434072 Method for preparing an aqueous solution enriched in both EG-III & xylanase using a low molecular weight alcohol and an organic salt |
| 07/18/1995 | US5434070 Reverse transcriptases from Escherichia coli and Myxococcus xanthus |
| 07/18/1995 | US5434068 Bacillus, gene expression |
| 07/18/1995 | US5434067 Process for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphatase |
| 07/18/1995 | US5434066 Modulation of CRE recombinase in the in vivo cloning of DNA |
| 07/18/1995 | US5434065 Genetic engineering and expression using auxotrophic or antibiotic sensitive microorganism's chromosome |
| 07/18/1995 | US5434064 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 07/18/1995 | US5434063 Genetic engineering |
| 07/18/1995 | US5434058 Apolipoprotein B MRNA editing protein compositions and methods |
| 07/18/1995 | US5434049 Separation of polynucleotides using supports having a plurality of electrode-containing cells |
| 07/18/1995 | US5433948 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/18/1995 | US5433945 Immunoprotective genetically-detoxified mutants of pertussis toxin |
| 07/18/1995 | CA1336329C Fusion proteins, a process for their preparation and their use |
| 07/14/1995 | CA2425551A1 Novel process, construct and conjugate for producing multiple nucleic acid copies |
| 07/13/1995 | WO1995018974A2 Ubiquitin conjugating enzymes |
| 07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
| 07/13/1995 | WO1995018862A2 tfdA GENE SELECTABLE MARKERS IN PLANTS AND THE USE THEREOF |
| 07/13/1995 | WO1995018861A1 Influenza vaccine |
| 07/13/1995 | WO1995018860A1 Control of marek's disease by the inhibition of latency and tumor cell development |
| 07/13/1995 | WO1995018859A1 Synergistic antifungal protein and compositions containing same |
| 07/13/1995 | WO1995018858A1 Thrombopoietin |
| 07/13/1995 | WO1995018857A1 Association of kinesin with sensitivity to chemotherapeutic drugs |
| 07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 07/13/1995 | WO1995018855A2 Synthetic antimicrobial peptides |
| 07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | WO1995018853A1 Mutant luciferases |
| 07/13/1995 | WO1995018852A1 Herpesvirus replication defective mutants |
| 07/13/1995 | WO1995018851A1 Process for reducing high-molecular structures |
| 07/13/1995 | WO1995018830A2 Inhibitors of human plasmin derived from the kunitz domains |
| 07/13/1995 | WO1995018829A1 Factor viii derivatives |
| 07/13/1995 | WO1995018828A1 Factor viii derivatives |
| 07/13/1995 | WO1995018827A1 Factor viii derivatives |
| 07/13/1995 | WO1995018826A2 Purified primate ctla-8 antigens and related reagents |
| 07/13/1995 | WO1995018825A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
| 07/13/1995 | WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/13/1995 | WO1995018822A1 NOVEL DEVELOPMENTALLY REGULATED λB ENHANCER BINDING PROTEINS |
| 07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
| 07/13/1995 | WO1995018813A1 Method for analyzing oligonucleotide analogs |
| 07/13/1995 | WO1995018676A1 Apparatus and method for thermal cycling nucleic acid assays |
| 07/13/1995 | WO1995018633A1 Soft agar penetration-defective mutants |
| 07/13/1995 | WO1995018631A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 07/13/1995 | WO1995018623A1 Oligomeric compounds having nitrogen-containing linkages |
| 07/13/1995 | WO1995018609A1 Human leukocyte 12-lipoxygenase, mediation of its pathway, and consequences thereof |
| 07/13/1995 | WO1995017524A3 Automatic genotype determination |
| 07/13/1995 | WO1995016035A3 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/13/1995 | WO1995015383A3 Biological control agents |
| 07/13/1995 | WO1995014782A3 A modified thermo resistant dna polymerase |
| 07/13/1995 | WO1995013095A3 Therapy |
| 07/13/1995 | WO1995011919A3 Recombinant pilc proteins, process for producing them and their use |
| 07/13/1995 | WO1995010619A3 Methods of increasing rates of infection by directing motion of vectors |
| 07/13/1995 | WO1995008631A3 Target antigens of transmission blocking antibodies for malaria parasites |
| 07/13/1995 | WO1995007357A3 Promoters |
| 07/13/1995 | WO1995006122A3 Recombinant alternaria alternata allergenes |
| 07/13/1995 | WO1995006121A3 Recombinant cladosporium herbarum allergens |
| 07/13/1995 | CA2181082A1 Oligomeric compounds having nitrogen-containing linkages |
| 07/13/1995 | CA2180644A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
| 07/13/1995 | CA2180551A1 Herpesvirus replication defective mutants |
| 07/13/1995 | CA2180531A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |